| PARP Inhibitor Efficacy Depends on CD8+ T-cell Recruitment via Intratumoral STING Pathway Activation in BRCA-Deficient Models of Triple-Negative Breast Cancer C Pantelidou, O Sonzogni, M De Oliveria Taveira, AK Mehta, A Kothari, ... Cancer discovery 9 (6), 722-737, 2019 | 576 | 2019 |
| A proteogenomic portrait of lung squamous cell carcinoma S Satpathy, K Krug, PMJ Beltran, SR Savage, F Petralia, C Kumar-Sinha, ... Cell 184 (16), 4348-4371. e40, 2021 | 268 | 2021 |
| MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance L Cornell, SA Wander, T Visal, N Wagle, GI Shapiro Cell reports 26 (10), 2667-2680. e7, 2019 | 138 | 2019 |
| Going circular: history, present, and future of circRNAs in cancer G Pisignano, DC Michael, TH Visal, R Pirlog, M Ladomery, GA Calin Oncogene 42 (38), 2783-2800, 2023 | 98 | 2023 |
| Circulating tumour cells in the-omics era: how far are we from achieving the ‘singularity’? TH Visal, P den Hollander, M Cristofanilli, SA Mani British journal of cancer 127 (2), 173-184, 2022 | 53 | 2022 |
| Stabilizing vimentin phosphorylation inhibits stem-like cell properties and metastasis of hybrid epithelial/mesenchymal carcinomas NA Kuburich, P den Hollander, M Castaneda, M Pietilä, X Tang, H Batra, ... Cell reports 42 (12), 2023 | 8 | 2023 |
| ON 123300, an orally administered novel CDK4/6+ ARK5 inhibitor, exhibits potent antitumor activity in vivo: comparative studies with Palbociclib S Patel, P Pancholi, T Visal, A Samant, D Kansara, VJ Rajadhyaksha, ... Cancer Res 77, 2172, 2017 | 1 | 2017 |
| Accumulation of CD38 in Hybrid Epithelial/Mesenchymal Cells Promotes Immune Remodeling and Metastasis in Breast Cancer TH Visal, R Bayraktar, P den Hollander, MA Attathikhun, T Zhou, J Wang, ... Cancer Research, OF1-OF18, 2025 | | 2025 |
| Intratumoral accumulation of CD38 enhances immune evasion and metastasis in models of breast cancer with EMT plasticity T Visal Cancer Research 84 (6_Supplement), 206-206, 2024 | | 2024 |
| Role of epithelial-mesenchymal plasticity in immune remodeling during metastasis TH Visal Cancer Research 82 (12_Supplement), 950-950, 2022 | | 2022 |
| PARP inhibitor efficacy depends on CD8+ T-cell recruitment via the STING pathway in BRCA-deficient models of triple-negative breast cancer C Pantelidou, O Sonzogni, MDO Taveira, AK Mehta, D Wang, A Kothari, ... Cancer Research 79 (13_Supplement), 4490-4490, 2019 | | 2019 |
| Palbociclib synergistically enhances the anticancer activity of cisplatin in P53 mutant model of upper gastrointestinal cancers D Kansara, A Samant, P Pancholi, T Visal, S Patel, V Sehdev Cancer Research 78 (13_Supplement), 5805-5805, 2018 | | 2018 |
| Design, synthesis, selection, and evaluation of a potent multi-kinase targeting N4-phenylsubstituted-7H-pyrrolo[2,3-d]pyrimidin-4-amine derivative with significant … A Samant, T Visal, P Pancholi, D Kansara, T Dichwalkar, R Senones, ... Cancer Research 78 (13_Supplement), 2800-2800, 2018 | | 2018 |
| RS-41, a multi-targeted kinase inhibitor, induces cell cycle arrest and apoptosis in p53 mutant and wild type models of upper gastrointestinal cancers T Visal Long Island University, The Brooklyn Center, 2017 | | 2017 |